(Q27690023)
Statements
Structure-based drug design of RN486, a potent and selective Bruton's tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritis (English)
0 references
8 January 2015
0 references
58
0 references
1
0 references
512-6
0 references